Our study showed that the contents of Sepp1 in plasma were accordingly 4.5 mg/mL for acute patients, 5.5 mg/mL 1st wave and 6.8 mg/mL 2nd wave post-COVID-19 patients. Here, SELENOP is linked to COVID-19.